Researchers at the University of California San Diego discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker...
Read More »Upcoming Webinar – Applications of TCR repertoire as a biomarker for immunotherapy and beyond
Date: Thursday, May 23, 2019Time: 10AM PDT | 1PM EDTSpeaker: Dr. Ankita DasCheckpoint inhibitors have produced durable responses, even cure, in patients who have failed all therapies. This phenomenon is unprecedented in cancer treatment...
Read More »Extremely precise RNA sequencing may improve detection and treatment of advanced brain cancer
In a new study, Yale Cancer Center scientists have demonstrated a powerful method to analyze how tumor cells are altered as they metastasize, or spread, to the brain. The research, published in the journal Cell Reports, may eventually improve early diagnosis and treatment ...
Read More »Biogazelle appoints Armin Winands as new CEO
Belgian genomics company Biogazelle appoints new CEO to spur rapid growth Biogazelle is pleased to announce the appointment of Armin Winands as its new CEO effective 1stJuly 2018, following Jan Hellemans who will take on the role of CTO after ...
Read More »Clinical value of RNA-Seq equivalent to histopathology classification of breast cancer biomarkers
In early breast cancer (BC), five conventional biomarkers—estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2), Ki67, and Nottingham histologic...
Read More »Antiviral response detected via RNA-Seq from nasal swabs predicts respiratory viral infection
Despite the high burden of respiratory infection and the importance of early and accurate diagnosis, there is no simple diagnostic test to rule in viral...
Read More »BARC and Biogazelle announce collaboration for advanced genetic testing in clinical trials
Bio Analytical Research Corporation (BARC), the global central laboratory division of Cerba HealthCare, today announces that Biogazelle will join the pool of expert laboratories they consistently collaborate with. BARC is a harmonized network of clinical laboratories present on five continents. ...
Read More »Imaging biopsies as effective as RNA-Seq?
A computational imaging-based signature of immune-cell infiltration in and around a tumor could predict patients’ responses to treatment with anti-PD1/PDL1 immunotherapies, according to data from a study presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held ...
Read More »A statistical framework for applying RNA profiling to chemical hazard detection
Use of ‘omics technologies in environmental science is expanding. However, application is mostly restricted to characterizing molecular steps leading from toxicant interaction with molecular receptors to apical endpoints in laboratory species. Use in environmental decision-making is limited, due to difficulty ...
Read More »Integration of RNA-Seq and RPPA data for survival time prediction in cancer patients
Integration of several types of patient data in a computational framework can accelerate the identification of more reliable biomarkers, especially for prognostic purposes. Researchers at Dokuz Eylul University aimed to identify biomarkers that can successfully predict the potential survival time ...
Read More »